Caffeine for Hypoxic-Ischemic Encephalopathy—Throwing Fuel on the Fire?

This Viewpoint describes the need for more preclinical work to increase confidence that caffeine is safe and beneficial as a postnatal treatment for hypoxic-ischemic encephalopathy before clinical trials are conducted.

Corresponding Author: Nicola J. Robertson, MBChB, PhD, Institute for Women’s Health, University College London, London WC1E 6HX, United Kingdom (n.robertson@ucl.ac.uk).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.